Copyright
©The Author(s) 2019.
World J Hepatol. Oct 27, 2019; 11(10): 719-724
Published online Oct 27, 2019. doi: 10.4254/wjh.v11.i10.719
Published online Oct 27, 2019. doi: 10.4254/wjh.v11.i10.719
Figure 1 A detailed drug chart in relation to the timing of onset of liver injury.
BD: Twice daily; OM: Every morning; LFT: Liver function test; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; T: Temperature.
Figure 2 Hepatic metabolism of escitalopram; S-demethylcitalopram, the principal metabolite, is present at one-third the level of escitalopram and the didemethyl metabolite of escitalopram is typically present at or below quantifiable concentrations.
- Citation: Ng QX, Yong CSK, Loke W, Yeo WS, Soh AYS. Escitalopram-induced liver injury: A case report and review of literature. World J Hepatol 2019; 11(10): 719-724
- URL: https://www.wjgnet.com/1948-5182/full/v11/i10/719.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i10.719